# Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee

> **NCT00980798** · PHASE3 · COMPLETED · sponsor: **Janssen-Cilag International NV** · enrollment: 288 (actual)

## Conditions studied

- Pain
- Osteoarthritis, Hip
- Osteoarthritis, Knee

## Interventions

- **DRUG:** OROS hydromorphone HCl
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00980798
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2014-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980798, "Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00980798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*